3-37494565-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002207.3(ITGA9):c.609C>T(p.Thr203=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0551 in 1,611,664 control chromosomes in the GnomAD database, including 2,732 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.045 ( 205 hom., cov: 33)
Exomes 𝑓: 0.056 ( 2527 hom. )
Consequence
ITGA9
NM_002207.3 synonymous
NM_002207.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.91
Genes affected
ITGA9 (HGNC:6145): (integrin subunit alpha 9) This gene encodes an alpha integrin. Integrins are heterodimeric integral membrane glycoproteins composed of an alpha chain and a beta chain that mediate cell-cell and cell-matrix adhesion. The protein encoded by this gene, when bound to the beta 1 chain, forms an integrin that is a receptor for VCAM1, cytotactin and osteopontin. Expression of this gene has been found to be upregulated in small cell lung cancers. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 3-37494565-C-T is Benign according to our data. Variant chr3-37494565-C-T is described in ClinVar as [Benign]. Clinvar id is 402988.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-37494565-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.91 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0665 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ITGA9 | NM_002207.3 | c.609C>T | p.Thr203= | synonymous_variant | 5/28 | ENST00000264741.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ITGA9 | ENST00000264741.10 | c.609C>T | p.Thr203= | synonymous_variant | 5/28 | 1 | NM_002207.3 | P1 | |
ITGA9 | ENST00000422441.5 | c.609C>T | p.Thr203= | synonymous_variant | 5/16 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0455 AC: 6922AN: 152172Hom.: 206 Cov.: 33
GnomAD3 genomes
AF:
AC:
6922
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0491 AC: 12312AN: 250738Hom.: 328 AF XY: 0.0504 AC XY: 6826AN XY: 135568
GnomAD3 exomes
AF:
AC:
12312
AN:
250738
Hom.:
AF XY:
AC XY:
6826
AN XY:
135568
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0560 AC: 81797AN: 1459374Hom.: 2527 Cov.: 31 AF XY: 0.0557 AC XY: 40454AN XY: 726126
GnomAD4 exome
AF:
AC:
81797
AN:
1459374
Hom.:
Cov.:
31
AF XY:
AC XY:
40454
AN XY:
726126
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0455 AC: 6926AN: 152290Hom.: 205 Cov.: 33 AF XY: 0.0454 AC XY: 3382AN XY: 74456
GnomAD4 genome
AF:
AC:
6926
AN:
152290
Hom.:
Cov.:
33
AF XY:
AC XY:
3382
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
189
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 5% of total chromosomes in ExAC - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at